29 Aug, EOD - Indian

Nifty Next 50 65745.75 (-0.30)

Nifty Smallcap 100 17227 (-0.39)

Nifty IT 35181.25 (-0.87)

SENSEX 79809.65 (-0.34)

Nifty Pharma 21804.05 (-0.02)

Nifty Bank 53655.65 (-0.31)

Nifty 50 24426.85 (-0.30)

Nifty Midcap 100 55727.4 (-0.57)

29 Aug, EOD - Global

NIKKEI 225 42718.47 (-0.26)

HANG SENG 25077.62 (0.32)

S&P 6484.75 (-0.69)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(21 Aug 2025, 15:25)

Concord Biotech gains after successful EU-GMP inspection at Limbassi facility

Concord Biotech rose 3.30% to Rs 1,748.70 after the company's API manufacturing facility in Limbassi completed its first EU-GMP inspection.


The inspection was conducted by EU-GMP authorities from 18 August to 21 August 2025. The company stated that this milestone marks a significant achievement, as the successful outcome not only validates its commitment to global quality standards but also opens avenues to expand its presence in international markets.

The EU-GMP approval will allow Concord to explore commercial opportunities across multiple EU territories and other regulated geographies, strengthening its global footprint and supporting its growth strategy.

Concord added that the inspection outcome reaffirms its commitment to the highest standards of quality, safety, and regulatory compliance, highlighting its focus on operational excellence and alignment with international regulatory expectations.

Concord Biotech is involved in manufacturing fermentation and semi-synthetic biopharmaceutical APIs with immunosuppressants as its key therapeutic segment.

The company's consolidated net profit fell 26.1% to Rs 44.06 crore on a 5.5% decline in revenue from operations to Rs 203.99 crore in Q1 FY26 over Q1 FY25.

More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +